"What Our Future Looks Like in a Post-Pandemic COVID-19

New Post Public Reply Private Reply Replies (0) Message Board
Murphalot
606
"What Our Future Looks Like in a Post-Pandemic COVID-19 World"

Quote:
Experts say COVID-19 will likely continue to fade in the United States, but the disease probably will not disappear.
They expect COVID-19 could be similar to the influenza virus that re-emerges every year in a slightly different form.
They say there are still many unknowns about the novel coronavirus that causes COVID-19, including how often it will mutate.
Though the COVID-19 pandemic is starting to fade in the United States, it’s unlikely that the novel coronavirus is going away, at least for the near future.

As case rates drop and more people become vaccinated, COVID-19 will likely transition from a pandemic – the worldwide spread of a new disease – to an endemic phase, where the virus is always present in the population in some form, albeit under controllable levels, experts say.

“It’s likely that it will become endemic because people carry it without knowing or showing symptoms, and some people have diminished immunity that will continue to make them susceptible even post-vaccination,” said Gerald Commissiong, CEO of Todos Medical, Ltd., a COVID-19 screening and testing company.

“Combined with the likelihood of waning immunity and emerging variants, we should expect that COVID-19 is a virus that will be with us for the long haul,” Commissiong told Healthline.


What about herd immunity?
Herd immunity – the level at which enough of the population is vaccinated that the disease can no longer spread and fades away – may be elusive for COVID-19.

Many experts think the United States will need at least 70 percent of the population to be immunized to achieve herd immunity, although it’s not certain yet what level will need to be achieved.

“We don’t know really what the required level of herd immunity is to keep COVID-19 out of circulation,” said Dr. Susan Kline, MPH, an infectious disease physician with the University of Minnesota Medical School and M Health. “For some diseases, a much higher level of vaccination is required to keep the disease from breaking out, e.g., measles, where it is estimated that 95 percent of the herd must be vaccinated or immune to keep the disease under control.”

While measles is caused by a different virus from coronavirus, it’s telling that even this virus that sees high childhood vaccination rates still emerges occasionally among regional populations with lower vaccination rates.

A similar dynamic could likely emerge with COVID-19.

“We don’t need to look very far to see what happens when there are low vaccination rates in populations,” Dr. Beth Oller, a family medicine physician in Kansas, told Healthline. “Measles is still a common disease in many parts of the world. The [Centers for Disease Control and Prevention] reported 1,282 measles cases in 31 states in 2019. This was the greatest number of cases reported in the U.S. since measles was eliminated from the country in 2000, and we came close to losing our measles elimination status.”

Ultimately, this means people will need to be mindful of their behavior and should not expect a total return to pre-pandemic behavior.

Instead, experts say we should endeavor to continue to observe masking and physical distancing protocols in groups of unfamiliar people and take a cautious approach to mingle with larger groups.

“If people forgo these precautions, this threatens the delicate and shifting balance of the herd,” Dr. Elizabeth Wang, an infectious diseases physician at the University of Maryland St. Joseph Medical Center, told Healthline. “For example, if a person pre-vaccination used to only interact with one person on a daily basis, he now believes post-vaccination he can meet 10 people without masking. How many people he’s meeting changes the entire herd immunity equation. If his social behavior once again begins to promote the spread of the virus, a higher percentage (more than 70 percent) will now need to be vaccinated in order to achieve herd immunity.”

CORONAVIRUS UPDATES
Stay on top of the COVID-19 pandemic
We’ll email you the latest developments about the novel coronavirus and Healthline's top health news stories, daily.

Enter your email
Your privacy is important to us

COVID-19’s unique challenges
There’s still a lot of unknowns when it comes to how often COVID-19 might mutate and how frequently people might require booster shots of the vaccine, among other issues.

“Influenza is somewhat predictable in how it changes yearly, so yearly flu vaccines can be mostly predicted – and there are vaccines on the horizon for influenza that may not need to be given yearly,” Dr. Jill Foster, a pediatric infectious disease physician with the University of Minnesota Medical School and M Health Fairview, told Healthline. “COVID, however, has demonstrated remarkable ability to mutate and change how easily it spreads and how severe disease is.

“For a while, it will be a race of vaccine coverage for it against the variants. So far, we’ve been winning, but one bad variant that spreads easily, causes severe disease, and evades vaccine, and we’ll be set back by months,” she added.

Written by Christopher Curley on June 3, 2


https://www.healthline.com/health-news/what-o...d-19-world

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 5

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 6

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Portable Battery Charger Set to Transform EV Charging

Updated Category News Views 207

Introduction to the New Battery Charger for Electric Vehicles In a world where electric vehicles (EVs) are becoming more prevalent, the quest for convenience and reliability in charging options has led to the creation of an exciting new product. An inventive mind has developed a portable battery charger designed specifically for electric cars, addressing the significant...

Continue Reading
How to Calculate Rental Property Returns in Calgary

Updated Category Real Estate Views 549

The growth of the future value is not sufficient to invest in rental property, particularly in a market place such as Calgary where the economic cycles and population dynamics may affect the results. By computing the returns on the rental property, investors are able to know whether a property will be able to produce sustainable returns as they accumulate long te

Continue Reading
Understanding BioCardia's Upcoming Earnings Announcement

Updated Category News Views 196

BioCardia's Anticipated Earnings Report BioCardia (NASDAQ: BCDA) is gearing up for its next quarterly earnings announcement. Investors are keen to hear the results as they look to gain insights into the company's performance and future expectations. Expected Earnings Per Share Current estimates suggest that BioCardia will report an earnings per share (EPS) of...

Continue Reading
A New Look at Trump's First Month and Children's Concerns

Updated Category News Views 501

President Trump's Impact During His Initial Month As President Trump's new term unfolds, impactful events are shaping his administration's direction. The first month has been marked by significant developments, highlighted by the Senate's confirmation of Kash Patel as the Director of the FBI. This move is seen as a pivotal moment, emphasizing a commitment to addressing...

Continue Reading
Eramet Faces Revenue Decrease Amid Logistics Hurdles

Updated Category News Views 286

Eramet Revenue Decline in Q3 2025 Eramet has reported a decline in its adjusted turnover for the third quarter of 2025, which totaled €720 million. This marks a 10% decrease compared to the same quarter in 2024. The decrease primarily stems from significant external factors affecting sales and market conditions. Safety and CSR Achievements Despite facing a challenging...

Continue Reading